Report DMCA Roche and Biogen Idec have suspended trials of ocrelizumab treatment in patients with rheumatoid arthritis due to safety
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.